Sutro Biopharma, Inc. STRO
Set alert
9.73 USD +0.62 +6.75%
As of Nov 3, 11:30 AM ET
9.03 Day range 9.84
7.15 52-week range 43.85
- YTD
- -15.95%
- 1 year
- -11.59%
- Open
- 9.20
- Prev close
- 9.11
- Mkt cap
- 162.00M
- Vol
- 35.37K
- Avg vol
- 312.81K
- EPS
- -17.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.03
- High
- 9.84
- Forward P/E
- -0.63
- Beta
- 0.00
- Short ratio
- 2.47
- Inst. own
- 77.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 3.12
- 200-d avg
- 3.73
- 1y target
- 11.50
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 11.50 +18.3% upside
Now 9.73
- Target (low)
- 4.00
- Target (mean)
- 11.50
- Target (high)
- 20.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy3
- Buy7
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.955 | -1.13 – -0.78 | 0.498 | -291.8% | 12.18M | -89.3% | 2 |
| Next quarter | -0.92 | -0.92 – -0.92 | -0.89 | -3.4% | 9.00M | -30.8% | 1 |
| Current year | -3.07 | -3.22 – -2.92 | -1.73 | -77.4% | 59.20M | -61.5% | 2 |
| Next year | -3.42 | -3.90 – -2.93 | -3.07 | -11.2% | 49.20M | -16.9% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 11, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 11, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Oct 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| May 14, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | B of A Securities | Initiated | — | Buy |
| Apr 3, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Apr 3, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 3, 2024 | Truist Securities | Maintained | Buy | Buy |
| Apr 3, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 28, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 27, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 26, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 26, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 26, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 15, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 9, 2023 | Deutsche Bank | Initiated | — | Buy |
| Oct 23, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Oct 6, 2023 | Oppenheimer | Initiated | — | Outperform |
| Sep 6, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Aug 14, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |